The deal also calls for DaVita to take over management of inpatient acute dialysis services at the hospital.
At a recent hearing, a nurses union and patient advocates voiced opposition to the deal. Concerns center on whether DaVita will put profits ahead of patients and “highjack” local physicians’ decisions about patient care, according to the report. Advocates of the sale contradicted the nurses union, arguing that DaVita is better than EMMC on many quality measures and has the expertise to manage the dialysis clinics successfully.
The deal will be reviewed by the Department of Health and Human Services, and a preliminary recommendation is expected in August.
More Articles on Eastern Maine Medical Center:
Eastern Maine Medical Center CNO Resigns
Eastern Maine Medical Center to Close 5 of 6 Retail Clinic Locations
Eastern Maine Medical Center’s Cost-Saving Measures Cause Job Cuts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit